Cuppens H, Marynen P, De Boeck C, Cassiman J J
Center for Human Genetics, University of Leuven, Belgium.
Genomics. 1993 Dec;18(3):693-7. doi: 10.1016/s0888-7543(05)80376-3.
We have previously shown that about 85% of the mutations in 194 Belgian cystic fibrosis alleles could be detected by a reverse dot-blot assay. In the present study, 50 Belgian chromosomes were analyzed for mutations in the cystic fibrosis transmembrane conductance regulator gene by means of direct solid phase automatic sequencing of PCR products of individual exons. Twenty-six disease mutations and 14 polymorphisms were found. Twelve of these mutations and 3 polymorphisms were not described before. With the exception of one mutant allele carrying two mutations, these mutations were the only mutations found in the complete coding region and their exon/intron boundaries. The total sensitivity of mutant CF alleles that could be identified was 98.5%. Given the heterogeneity of these mutations, most of them very rare, CFTR mutation screening still remains rather complex in our population, and population screening, whether desirable or not, does not appear to be technically feasible with the methods currently available.
我们之前已经表明,通过反向斑点杂交分析可以检测出194个比利时囊性纤维化等位基因中约85%的突变。在本研究中,通过对各个外显子的PCR产物进行直接固相自动测序,分析了50条比利时染色体上囊性纤维化跨膜传导调节基因的突变情况。发现了26种疾病突变和14种多态性。其中12种突变和3种多态性之前未被描述。除了一个携带两种突变的突变等位基因外,这些突变是在完整编码区及其外显子/内含子边界中发现的唯一突变。可识别的突变CF等位基因的总灵敏度为98.5%。鉴于这些突变的异质性,其中大多数非常罕见,在我们的人群中,CFTR突变筛查仍然相当复杂,而且无论是否需要进行人群筛查,使用目前可用的方法在技术上似乎都不可行。